Curative Biosciences, Inc.

OTCPK:CBDX Stock Report

Market Cap: US$257.0

Curative Biosciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Richard Damion

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure9.8yrs
CEO ownershipn/a
Management average tenure9.8yrs
Board average tenure11yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Richard Damion (81 yo)

9.8yrs

Tenure

Mr. Richard Damion founded Newport Digital Technologies, Inc. (a/k/a International Food Products Group Inc.) and has been its Chief Executive Officer since August 2012. Mr. Damion has been the Chief Execut...


Leadership Team

NamePositionTenureCompensationOwnership
Richard Damion
Chairman & CEO9.8yrsno datano data
A. Grandsaert
President9.8yrsno datano data
William Lindberg
CFO & Director14.1yrsUS$37.50kno data
Katherine T. West
Executive VPno datano datano data

9.8yrs

Average Tenure

81yo

Average Age

Experienced Management: CBDX's management team is seasoned and experienced (9.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Richard Damion
Chairman & CEO11yrsno datano data
William Lindberg
CFO & Director14.1yrsUS$37.50kno data
Katherine T. West
Executive VP10.8yrsno datano data

11.0yrs

Average Tenure

81yo

Average Age

Experienced Board: CBDX's board of directors are seasoned and experienced ( 11 years average tenure).